PT Famon Awal Bros Sedaya Tbk (PRAY.JK)
IDR 640.0
(-2.29%)
IDR 640.0
(-2.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 443.01 Billion IDR | 75.77% |
| 2022 | 251.37 Billion IDR | -65.54% |
| 2021 | 644.01 Billion IDR | 35.42% |
| 2020 | 482.18 Billion IDR | 95.32% |
| 2019 | 251.96 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 99.39 Billion IDR | -12.96% |
| 2024 Q1 | 116.62 Billion IDR | 16.05% |
| 2024 Q3 | 128.55 Billion IDR | 28.63% |
| 2023 Q2 | 87.78 Billion IDR | -7.11% |
| 2023 Q1 | 94.49 Billion IDR | 217.39% |
| 2023 FY | - IDR | 75.77% |
| 2023 Q4 | 85.41 Billion IDR | -24.26% |
| 2023 Q3 | 112.78 Billion IDR | 28.48% |
| 2022 Q1 | 77.06 Billion IDR | 0.0% |
| 2022 FY | - IDR | -65.54% |
| 2022 Q4 | 29.77 Billion IDR | -49.49% |
| 2022 Q3 | 58.95 Billion IDR | 16.32% |
| 2022 Q2 | 50.68 Billion IDR | -34.24% |
| 2021 FY | - IDR | 35.42% |
| 2020 FY | - IDR | 95.32% |
| 2019 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | -97.854% |
| PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 5868.202% |
| PT Medikaloka Hermina Tbk | 1584.42 Billion IDR | 72.04% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | 71.518% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | -184.698% |
| PT Royal Prima Tbk | 52.4 Billion IDR | -745.311% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -624.798% |
| PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | -37.076% |
| PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 83.546% |
| PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | -1.322% |